Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Hakim‐Moulay Dehbi(MRC Clinical Trials Unit at UCL), David J. Werring(Queen Mary University of London), Amalia Ndoutoumou(MRC Clinical Trials Unit at UCL), Götz Thomalla(Universität Hamburg), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Truman J. Milling(Population Health Research Institute), Susan Massingham(MRC Clinical Trials Unit at UCL), Nick Freemantle(MRC Clinical Trials Unit at UCL), Tatevik Ghukasyan Lakic(Uppsala University), Masatoshi Koga(National Cerebral and Cardiovascular Center), Thomas Gattringer(Medical University of Graz), Philip S. Nash(National Hospital for Neurology and Neurosurgery), Nikola Sprigg(Nottingham University Hospitals NHS Trust), Patrick Lawrence(The University of Texas at Austin), Stefan T. Engelter(University Hospital of Basel), Jesse Dawson(University of Glasgow), Stefanie Abend(University Hospital of Basel), Bo Norrving(Lund University), Steven Warach(The University of Texas at Austin), Norin Ahmed(MRC Clinical Trials Unit at UCL), Ziad Hijazi(Uppsala University), Signild Åsberg(Uppsala University), Jonas Oldgren(Uppsala University), Tishok Vanniyasingam(MRC Clinical Trials Unit at UCL), Martin James(Royal Devon and Exeter Hospital), Georgia Salanti(University of Bern), Mattia Branca, Gregory Y H Lip(University of Liverpool), Lisa A Davis(The University of Texas at Austin), P O Wester(Umeå University), Urs Fischer(University Hospital of Bern)
The Lancet
June 23, 2025
Cited by 33


Related Papers